These results indicated that the efficacy of PCPs on chemotherapy-associated body weight loss, muscle fiber atrophy, and adipose tissue wasting in a cachexia mouse model exhibited a dose-dependent trend, similar to the effect of FFAR2. The gene discussed is FFAR2; the disease is Cachexia.